Genalyte, Inc.
Biotechnology ResearchCalifornia, United States51-200 Employees
Genalyte, Inc. is a biotechnology research company located in San Diego, California, at 6620 Mesa Ridge Road, 92121. The company employs between 51 and 200 people. Genalyte delivers real-time, point-of-care blood diagnostics and analytics, with a website at genalyte.com. It has developed SARS-CoV-2 diagnostics, including a SARS-CoV-2 Multi-Antigen Serology Panel, and received FDA Emergency Use Authorization for a rapid COVID-19 antibody test in 2020. The company has engaged in financing rounds and partnerships, including Verily as lead investor in a 2021 round and a strategic partnership with Burjeel Holdings announced in 2025 at Abu Dhabi Global Health Week. Revenue is reported in the range of $25 million to $50 million, and the company has raised funding.